Detail Information
Publications
The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell linesImmanual Joseph
Geron Corporation, Menlo Park, California 94025, USA
Cancer Res 70:9494-504. 2010..Our results suggest that imetelstat-mediated depletion of CSCs may offer an alternative mechanism by which telomerase inhibition may be exploited for cancer therapy...
